Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us dr. W.J. Plattel

Publications

Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials

Dynamics of circulating tumour DNA in relapsed/refractory diffuse large B-cell lymphoma patients

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up

Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial

Impact of Rituximab Maintenance on Survival in Patients with Mantle Cell Lymphoma; a Population-based Cohort Study

Phase 1/1b study of BCMA-targeting bispecific T-cell engager pavurutamab in relapsed/refractory multiple myeloma

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients

Real-World Outcomes of High Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Multiple Myeloma Older and Younger Than 65 Years

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial

Press/media

Hodgkin-Lymphom Serumtiter könnten Erkrankten mit negativem PET intensivere Therapie ersparen

Protonentherapie voor mediastinale lymfomen

Sustainable Development Goals

SDG 3 - Good Health and Well-being

More information about the Sustainable Development Goals.